OneSource Consulting

J&J stent tops Medtronic’s in Danish study – Reuters


Angioplasty.Org

J&J stent tops Medtronic's in Danish study
Reuters
ATLANTA, March 15 (Reuters) – Johnson & Johnson's (JNJ.N) Cypher drug-coated stent led to significantly fewer heart attacks, deaths and need for repeat procedures than Medtronic Inc's (MDT.N) newer Endeavor stent using a different drug, according to a
Denmark Study Shows J&J Heart Stent Topping Medtronic Stent Wall Street Journal
SORT OUT III: Cypher bests Endeavor at 18 months TheHeart.Org
Medtronic Says Heart-Stent Study May Have Favored Rival Device BusinessWeek
Angioplasty.Org  - RTT News  - MarketWatch (press release)
all 24 news articles »

* * * * * * * * * * * * * * * * * * * * * * * * * * * * *

OneSource Consulting

- Management Consulting
- Pricing Optimization
- Process Reengineering
- CrowdFunding

CLICK HERE

* * * * * * * * * * * * * * * * * * * * * * * * * * * * *

Tags: , , , , , , , , , , , , , , , , , , , , , , ,

Posted in Business and Business Research and Business Restructuring and Business Turnaround and Feasibility Studies and Health and Uncategorized by Health - Google News on March 15th, 2010 at 9:35 am.

Add a comment

Comments are closed.

Switch to our mobile site